Transcription	B-protein
factor	I-protein
AP-4	I-protein
is	O
a	O
ligand	B-protein
for	O
immunoglobulin-kappa	B-DNA
promoter	I-DNA
E-box	I-DNA
elements	I-DNA
.	O

Immunoglobulin	B-DNA
(	I-DNA
Ig	I-DNA
)	I-DNA
-kappa	I-DNA
promoters	I-DNA
from	O
humans	O
and	O
mice	O
share	O
conserved	B-DNA
sequences	I-DNA
.	O

The	O
octamer	B-DNA
element	I-DNA
is	O
common	O
to	O
all	O
Ig	B-DNA
promoters	I-DNA
and	O
pivotal	O
for	O
their	O
function	O
.	O

However	O
,	O
other	O
conserved	B-DNA
sequence	I-DNA
motifs	I-DNA
,	O
that	O
differ	O
between	O
Ig	B-DNA
variable	I-DNA
gene	I-DNA
families	I-DNA
,	O
are	O
required	O
for	O
normal	O
promoter	O
function	O
.	O

These	O
conserved	O
motifs	O
do	O
not	O
stimulate	O
transcription	O
in	O
the	O
absence	O
of	O
an	O
octamer	B-DNA
.	O

One	O
example	O
is	O
an	O
E-box	B-DNA
of	O
the	O
E47/E12	B-DNA
type	I-DNA
(	I-DNA
5'-CAGCTG-3	I-DNA
'	I-DNA
)	I-DNA
,	O
which	O
is	O
found	O
in	O
all	O
promoters	O
of	O
the	O
human	B-DNA
and	I-DNA
murine	I-DNA
Ig-kappa	I-DNA
gene	I-DNA
subgroups/families	I-DNA
,	O
with	O
the	O
exception	O
of	O
subgroups	O
II	O
and	O
VI	O
and	O
their	O
related	O
murine	B-DNA
families	I-DNA
.	O

In	O
the	O
present	O
study	O
we	O
show	O
that	O
the	O
ubiquitously	O
expressed	O
transcription	B-protein
factor	I-protein
AP-4	I-protein
,	O
and	O
not	O
E47	B-protein
,	O
interacts	O
specifically	O
with	O
the	O
kappa	B-DNA
promoter	I-DNA
E-boxes	I-DNA
when	O
tested	O
in	O
electrophoretic	O
mobility-shift	O
assays	O
using	O
nuclear	O
extracts	O
derived	O
from	O
human	B-cell_line
and	I-cell_line
murine	I-cell_line
B-cell	I-cell_line
lines	I-cell_line
.	O

Furthermore	O
,	O
AP-4	B-protein
,	O
unlike	O
E47	B-protein
,	O
did	O
not	O
act	O
as	O
a	O
transactivator	B-protein
,	O
which	O
is	O
in	O
agreement	O
with	O
previous	O
studies	O
on	O
intact	O
kappa	B-DNA
promoters	I-DNA
,	O
showing	O
that	O
transcription	O
is	O
absent	O
when	O
the	O
octamer	B-DNA
element	I-DNA
has	O
been	O
mutated	O
.	O

Based	O
on	O
these	O
data	O
,	O
and	O
the	O
conservation	O
of	O
the	O
5'-CAGCTG-3	B-DNA
'	I-DNA
motif	I-DNA
among	O
human	B-DNA
and	I-DNA
murine	I-DNA
kappa	I-DNA
promoters	I-DNA
,	O
we	O
propose	O
that	O
AP-4	B-protein
is	O
the	O
major	B-protein
ligand	I-protein
for	O
Ig-kappa	B-DNA
promoter	I-DNA
E-boxes	I-DNA
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
2001	NULL
)	NULL
354	NULL
,	NULL
431-438	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
431	NULL
Transcription	NULL
factor	NULL
AP-4	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
immunoglobulin-x	NULL
promoter	NULL
E-box	NULL
elements	NULL
Alaitz	NULL
ARANBURU	NULL
'	NULL
!	NULL

,	NULL
Robert	NULL
CARLSSON	NULL
,	NULL
Christine	NULL
PERSSON	NULL
and	NULL
Tomas	NULL
LEANDERSON	NULL
Section	NULL
for	NULL
Immunology	NULL
,	NULL
Department	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Lund	NULL
University	NULL
,	NULL
BMC	NULL
113	NULL
,	NULL
$	NULL
-22184	NULL
Lund	NULL
,	NULL
Sweden	NULL
Immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
-	NULL
«	NULL
promoters	NULL
from	NULL
humans	NULL
and	NULL
mice	NULL
share	NULL
conserved	NULL
sequences	NULL
.	NULL

The	NULL
octamer	NULL
element	NULL
is	NULL
common	NULL
to	NULL
all	NULL
Ig	NULL
promoters	NULL
and	NULL
pivotal	NULL
for	NULL
their	NULL
function	NULL
.	NULL

However	NULL
,	NULL
other	NULL
conserved	NULL
sequence	NULL
motifs	NULL
,	NULL
that	NULL
differ	NULL
between	NULL
Ig	NULL
variable	NULL
gene	NULL
families	NULL
,	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
promoter	NULL
function	NULL
.	NULL

These	NULL
conserved	NULL
motifs	NULL
do	NULL
not	NULL
stimulate	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
octamer	NULL
.	NULL

One	NULL
example	NULL
is	NULL
an	NULL
E-box	NULL
of	NULL
the	NULL
E47/E12	NULL
type	NULL
(	NULL
5-CAGCTG-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
is	NULL
found	NULL
in	NULL
all	NULL
promoters	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
Ig-	NULL
«	NULL
gene	NULL
subgroups/families	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
subgroups	NULL
II	NULL
and	NULL
VI	NULL
and	NULL
their	NULL
related	NULL
murine	NULL
families	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
show	NULL
that	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
AP-4	NULL
,	NULL
and	NULL
not	NULL
E47	NULL
,	NULL
interacts	NULL
specifically	NULL
with	NULL
the	NULL
x	NULL
promoter	NULL
E-boxes	NULL
when	NULL
tested	NULL
in	NULL
electrophoretic	NULL
mobility-shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
human	NULL
and	NULL
murine	NULL
B-cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
,	NULL
AP-4	NULL
,	NULL
unlike	NULL
E47	NULL
,	NULL
did	NULL
not	NULL
act	NULL
as	NULL
a	NULL
transactivator	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
on	NULL
intact	NULL
x	NULL
promoters	NULL
,	NULL
showing	NULL
that	NULL
transcription	NULL
is	NULL
absent	NULL
when	NULL
the	NULL
octamer	NULL
element	NULL
has	NULL
been	NULL
mutated	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
data	NULL
,	NULL
and	NULL
the	NULL
conservation	NULL
of	NULL
the	NULL
5-CAGCTG-3	NULL
'	NULL
motif	NULL
among	NULL
human	NULL
and	NULL
murine	NULL
x	NULL
promoters	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
AP-4	NULL
is	NULL
the	NULL
major	NULL
ligand	NULL
for	NULL
Ig-	NULL
«	NULL
promoter	NULL
E-boxes	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
bHLH-Zip	NULL
protein	NULL
,	NULL
conserved	NULL
sequences	NULL
,	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

INTRODUCTION	NULL
Immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
-	NULL
«	NULL
V	NULL
gene	NULL
sequences	NULL
from	NULL
humans	NULL
and	NULL
mice	NULL
have	NULL
been	NULL
classified	NULL
into	NULL
a	NULL
number	NULL
of	NULL
subgroups	NULL
and	NULL
families	NULL
,	NULL
respectively	NULL
,	NULL
according	NULL
to	NULL
sequence	NULL
similarities	NULL
in	NULL
their	NULL
coding	NULL
regions	NULL
[	NULL
1,2	NULL
]	NULL
.	NULL

However	NULL
,	NULL
Vx	NULL
gene	NULL
conservation	NULL
also	NULL
extends	NULL
into	NULL
the	NULL
promoter	NULL
regions	NULL
.	NULL

Although	NULL
the	NULL
octamer	NULL
motif	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
are	NULL
the	NULL
only	NULL
elements	NULL
that	NULL
are	NULL
conserved	NULL
in	NULL
all	NULL
Vr	NULL
promoters	NULL
,	NULL
other	NULL
elements	NULL
are	NULL
conserved	NULL
within	NULL
different	NULL
subgroups	NULL
and	NULL
families	NULL
[	NULL
3,4	NULL
]	NULL
.	NULL

The	NULL
octamer	NULL
interacts	NULL
with	NULL
the	NULL
Oct	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
[	NULL
5	NULL
]	NULL
.	NULL

It	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
normal	NULL
function	NULL
of	NULL
Ig	NULL
promoters	NULL
,	NULL
since	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
that	NULL
abrogate	NULL
Oct	NULL
binding	NULL
result	NULL
in	NULL
levels	NULL
of	NULL
transcription	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
a	NULL
TATA	NULL
box	NULL
only	NULL
[	NULL
6-8	NULL
]	NULL
.	NULL

However	NULL
,	NULL
a	NULL
minimal	NULL
Ig	NULL
promoter	NULL
containing	NULL
an	NULL
octamer	NULL
as	NULL
the	NULL
sole	NULL
upstream	NULL
element	NULL
can	NULL
only	NULL
stimulate	NULL
10-20	NULL
%	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
seen	NULL
with	NULL
an	NULL
intact	NULL
x	NULL
promoter	NULL
[	NULL
7,9	NULL
]	NULL
.	NULL

Hence	NULL
,	NULL
«	NULL
promoters	NULL
are	NULL
dependent	NULL
on	NULL
additional	NULL
functional	NULL
DNA	NULL
elements	NULL
for	NULL
full	NULL
activity	NULL
[	NULL
9,10	NULL
]	NULL
.	NULL

These	NULL
co-stimulatory	NULL
elements	NULL
,	NULL
however	NULL
,	NULL
are	NULL
not	NULL
capable	NULL
of	NULL
stimulating	NULL
transcription	NULL
by	NULL
themselves	NULL
but	NULL
are	NULL
strictly	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
octamer	NULL
element	NULL
for	NULL
activity	NULL
.	NULL

Thus	NULL
«	NULL
promoter	NULL
function	NULL
is	NULL
based	NULL
on	NULL
functional	NULL
modularity	NULL
[	NULL
10	NULL
]	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
co-stimulatory	NULL
DNA	NULL
elements	NULL
are	NULL
conserved	NULL
within	NULL
Vx	NULL
subgroups	NULL
/families	NULL
and	NULL
between	NULL
species	NULL
,	NULL
and	NULL
some	NULL
are	NULL
not	NULL
[	NULL
4	NULL
]	NULL
.	NULL

Examples	NULL
of	NULL
the	NULL
former	NULL
are	NULL
the	NULL
E-box	NULL
motifs	NULL
that	NULL
are	NULL
conserved	NULL
within	NULL
the	NULL
human	NULL
Vx	NULL
subgroups	NULL
I	NULL
,	NULL
III	NULL
,	NULL
IV	NULL
,	NULL
V	NULL
and	NULL
VII	NULL
and	NULL
the	NULL
related	NULL
murine	NULL
families	NULL
,	NULL
and	NULL
the	NULL
CCCT	NULL
motif	NULL
that	NULL
is	NULL
conserved	NULL
within	NULL
the	NULL
human	NULL
Vx	NULL
II	NULL
subgroup	NULL
and	NULL
its	NULL
related	NULL
murine	NULL
families	NULL
[	NULL
4	NULL
]	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
E-boxes	NULL
found	NULL
in	NULL
Vx	NULL
promoters	NULL
are	NULL
of	NULL
the	NULL
E2A	NULL
type	NULL
CANCTG-3	NULL
'	NULL
)	NULL
[	NULL
4	NULL
]	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
potential	NULL
recognition	NULL
sites	NULL
for	NULL
the	NULL
£24	NULL
gene	NULL
products	NULL
E47	NULL
and	NULL
E12	NULL
[	NULL
11	NULL
]	NULL
.	NULL

However	NULL
,	NULL
this	NULL
represents	NULL
a	NULL
paradox	NULL
,	NULL
since	NULL
the	NULL
£24	NULL
gene	NULL
products	NULL
are	NULL
intrinsically	NULL
potent	NULL
activators	NULL
of	NULL
transcription	NULL
[	NULL
12-14	NULL
]	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
proteins	NULL
interact	NULL
in	NULL
vitro	NULL
with	NULL
«	NULL
k	NULL
promoter	NULL
E-boxes	NULL
[	NULL
15,16	NULL
]	NULL
.	NULL

However	NULL
,	NULL
E47	NULL
,	NULL
although	NULL
reported	NULL
to	NULL
bind	NULL
optimally	NULL
to	NULL
the	NULL
E-box	NULL
sequence	NULL
5-CAGCTG-3	NULL
'	NULL
[	NULL
17	NULL
]	NULL
,	NULL
interacted	NULL
poorly	NULL
with	NULL
x-promoter	NULL
E-boxes	NULL
[	NULL
18	NULL
]	NULL
,	NULL
indicating	NULL
that	NULL
some	NULL
other	NULL
bHLH	NULL
protein	NULL
might	NULL
be	NULL
the	NULL
E-box	NULL
binding	NULL
factor	NULL
.	NULL

AP-4	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
bHLH-Zip	NULL
subgroup	NULL
of	NULL
bHLH	NULL
proteins	NULL
,	NULL
that	NULL
binds	NULL
the	NULL
5'-CAGCTG-3	NULL
'	NULL
motif	NULL
[	NULL
19	NULL
]	NULL
.	NULL

It	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
simian	NULL
virus	NULL
(	NULL
SV	NULL
)	NULL
40	NULL
enhancer	NULL
,	NULL
and	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
synergistically	NULL
with	NULL
AP-1	NULL
to	NULL
increase	NULL
transcription	NULL
in	NULL
vitro	NULL
from	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
[	NULL
20	NULL
]	NULL
.	NULL

Dimerization	NULL
of	NULL
bHLH	NULL
proteins	NULL
through	NULL
the	NULL
helix-loop-helix	NULL
domain	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
specific	NULL
DNA	NULL
binding	NULL
via	NULL
a	NULL
short	NULL
region	NULL
of	NULL
basic	NULL
residues	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
bHLH-Zip	NULL
proteins	NULL
possess	NULL
a	NULL
second	NULL
dimerization	NULL
domain	NULL
,	NULL
the	NULL
leucine	NULL
zipper	NULL
[	NULL
21	NULL
]	NULL
.	NULL

AP-4	NULL
is	NULL
unique	NULL
in	NULL
that	NULL
it	NULL
contains	NULL
an	NULL
additional	NULL
leucine	NULL
zipper	NULL
.	NULL

Hence	NULL
,	NULL
AP-4	NULL
presents	NULL
a	NULL
specific	NULL
tripartite	NULL
dimerization	NULL
structure	NULL
,	NULL
suggesting	NULL
that	NULL
AP-4	NULL
may	NULL
interact	NULL
with	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
transcription	NULL
factors	NULL
[	NULL
19	NULL
]	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
no	NULL
known	NULL
heterodimerization	NULL
partners	NULL
of	NULL
AP-4	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
Drosophila	NULL
homologue	NULL
of	NULL
human	NULL
AP-4	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
shows	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
similarity	NULL
to	NULL
the	NULL
human	NULL
and	NULL
Caenorhabditis	NULL
elegans	NULL
counterparts	NULL
within	NULL
the	NULL
bHLH-Zip	NULL
domain	NULL
,	NULL
the	NULL
second	NULL
leucine	NULL
zipper	NULL
and	NULL
a	NULL
third	NULL
conserved	NULL
region	NULL
of	NULL
unknown	NULL
function	NULL
[	NULL
22	NULL
]	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
show	NULL
that	NULL
AP-4	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
x-promoter	NULL
E-boxes	NULL
,	NULL
indicating	NULL
an	NULL
important	NULL
and	NULL
novel	NULL
role	NULL
for	NULL
this	NULL
ubiquitously	NULL
expressed	NULL
regulator	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
lincage-restricted	NULL
genes	NULL
.	NULL

EXPERIMENTAL	NULL
Plasmids	NULL
A	NULL
DNA	NULL
fragment	NULL
encoding	NULL
full-length	NULL
AP-4	NULL
[	NULL
17	NULL
]	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
R.	NULL
B.	NULL
Gaynor	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
75235-8594	NULL
,	NULL
U.S.A.	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pGEM®-3Z	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

To	NULL
create	NULL
an	NULL
expression	NULL
plasmid	NULL
containing	NULL
a	NULL
Myc	NULL
Abbreviations	NULL
used	NULL
:	NULL
bHLH	NULL
,	NULL
basic	NULL
helix-loop-helix	NULL
;	NULL
bHLH-Zip	NULL
,	NULL
bHLH	NULL
zipper	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
HIV-1	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type-1	NULL
;	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
pd	NULL
,	NULL
pentadecamer	NULL
;	NULL
SV	NULL
,	NULL
simian	NULL
virus	NULL
.	NULL

!	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
(	NULL
e-mail	NULL
Alaitz.Aranburu	NULL
@	NULL
immuno.lu.se	NULL
)	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
432	NULL
A.	NULL
Aranburu	NULL
and	NULL
others	NULL
epitope	NULL
tagged	NULL
version	NULL
of	NULL
AP-4	NULL
,	NULL
AP-4	NULL
cDNA	NULL
was	NULL
PCR	NULL
amplified	NULL
using	NULL
the	NULL
5	NULL
primer	NULL
:	NULL
5-4	NULL
(	NULL
GCGGATCCCATATGGAGTATTT-CATGGTGCCCACT	NULL
)	NULL
and	NULL
the	NULL
3	NULL
T7	NULL
primer	NULL
:	NULL
5d	NULL
(	NULL
TAATACG-ACTCACTATAGGG	NULL
)	NULL
with	NULL
the	NULL
AP-4-pGEM3Z	NULL
vector	NULL
as	NULL
template	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
excised	NULL
with	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
a	NULL
BamHI/EcoRI-excised	NULL
MD3	NULL
vector	NULL
resulting	NULL
in	NULL
plasmid	NULL
AP-4MD3	NULL
.	NULL

The	NULL
MD3	NULL
vector	NULL
contains	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
myc-epitope	NULL
inserted	NULL
into	NULL
peDNA3	NULL
,	NULL
as	NULL
described	NULL
in	NULL
[	NULL
14	NULL
]	NULL
.	NULL

The	NULL
peDNA3	NULL
vector	NULL
encoding	NULL
Syrian	NULL
hamster	NULL
E47	NULL
cDNA	NULL
(	NULL
EA47-pcDNA3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
plasmid	NULL
encoding	NULL
a	NULL
Myc-epitope-tagged	NULL
version	NULL
of	NULL
E47	NULL
(	NULL
E47	NULL
cDNA	NULL
cloned	NULL
into	NULL
MD3-E47MD3	NULL
)	NULL
are	NULL
also	NULL
described	NULL
in	NULL
[	NULL
14	NULL
]	NULL
.	NULL

The	NULL
4	NULL
x	NULL
pd-luciferase	NULL
reporter	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
a	NULL
PCR-amplified	NULL
4x	NULL
pd	NULL
fragment	NULL
into	NULL
the	NULL
basal	NULL
fos	NULL
reporter	NULL
(	NULL
pGL3fos	NULL
)	NULL
[	NULL
14	NULL
]	NULL
.	NULL

The	NULL
pGL3fos	NULL
contains	NULL
sequences	NULL
-56	NULL
to	NULL
+109	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
cloned	NULL
into	NULL
pGL3Basic	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
4	NULL
x	NULL
pd-fragment	NULL
was	NULL
made	NULL
using	NULL
the	NULL
5°	NULL
SP6	NULL
primer	NULL
:	NULL
5	NULL
'd	NULL
(	NULL
TAT-TTAGGTGACACTATAG	NULL
)	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
:	NULL
5d	NULL
(	NULL
ATAAGA-TCTAA	NULL
TCATGCCTGCA	NULL
)	NULL
,	NULL
with	NULL
the	NULL
4x	NULL
pdTATACAT-E	NULL
construct	NULL
as	NULL
a	NULL
template	NULL
[	NULL
15	NULL
]	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
Bgill	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
Sacl/Bg/lI-digested	NULL
pGL3fos	NULL
.	NULL

The	NULL
4	NULL
x	NULL
pdpGL3fos	NULL
plasmid	NULL
was	NULL
sequenced	NULL
over	NULL
the	NULL
4	NULL
x	NULL
pd	NULL
insert	NULL
.	NULL

The	NULL
2	NULL
x	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
introducing	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
4E2-uE5-containing	NULL
region	NULL
of	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
intron	NULL
enhancer	NULL
into	NULL
the	NULL
pGL3fos	NULL
,	NULL
as	NULL
described	NULL
in	NULL
[	NULL
14	NULL
]	NULL
.	NULL

Plasmids	NULL
MD3	NULL
,	NULL
E47-peDNA3	NULL
,	NULL
E47MD3	NULL
,	NULL
pGL3fos	NULL
and	NULL
2	NULL
x	NULL
(	NULL
uE2u4E5	NULL
)	NULL
fos	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Sigvardsson	NULL
.	NULL

Nuclear	NULL
extracts	NULL
,	NULL
proteins	NULL
translated	NULL
in	NULL
vifro	NULL
and	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
B-lymphoid	NULL
(	NULL
human	NULL
:	NULL
Raji	NULL
,	NULL
Namalwa	NULL
,	NULL
BJAB	NULL
;	NULL
murine	NULL
:	NULL
K46R	NULL
and	NULL
$	NULL
194	NULL
)	NULL
and	NULL
non-lymphoid	NULL
(	NULL
HeLa	NULL
)	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stimulated	NULL
(	NULL
72	NULL
h	NULL
)	NULL
primary	NULL
murine	NULL
spleen	NULL
cells	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

[	NULL
23	NULL
]	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
AP-4	NULL
and	NULL
E47	NULL
were	NULL
made	NULL
using	NULL
the	NULL
AP-4-pGEM3Z	NULL
plasmid	NULL
or	NULL
the	NULL
E47-pecDNA3	NULL
plasmid	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
TNT	NULL
Coupled	NULL
Reticulocyte	NULL
Lysate	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

For	NULL
EMSAs	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
proteins	NULL
or	NULL
2	NULL
wl	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
15	NULL
wl	NULL
of	NULL
binding	NULL
buffer	NULL
[	NULL
20	NULL
mM	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
6.0	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.01	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.1	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
ug/ml	NULL
BSA	NULL
and	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Ficoll	NULL
]	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
competitors	NULL
or	NULL
antibodies	NULL
directed	NULL
against	NULL
E47	NULL
(	NULL
1	NULL
wl	NULL
,	NULL
Santa	NULL
Cruz	NULL
sc-763	NULL
X	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
,	NULL
U.S.A.	NULL
)	NULL
or	NULL
AP-4	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
R.	NULL
B.	NULL
Gaynor	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

*°P-Labelled	NULL
probe	NULL
samples	NULL
(	NULL
30000	NULL
c.p.m	NULL
.	NULL
)	NULL

were	NULL
added	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
kept	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
before	NULL
resolution	NULL
by	NULL
PAGE	NULL
(	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
)	NULL
in	NULL
TBE	NULL
[	NULL
0.09	NULL
M	NULL
Tris/borate	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
/2	NULL
mM	NULL
EDTA	NULL
]	NULL
.	NULL

Probes	NULL
and	NULL
competitors	NULL
°*°P-Labelled	NULL
or	NULL
unlabelled	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
to	NULL
unlabelled	NULL
antisense	NULL
oligonucleotides	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
respectively	NULL
.	NULL

The	NULL
sense-strand	NULL
sequence	NULL
of	NULL
each	NULL
of	NULL
the	NULL
different	NULL
oligonucleotides	NULL
used	NULL
in	NULL
EMSA	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
transfections	NULL
Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
with	NULL
glutamine	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
supplemented	NULL
with	NULL
7-8	NULL
%	NULL
fetal-calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
1	NULL
mM	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
sodium	NULL
pyruvate	NULL
and	NULL
50	NULL
ug/ml	NULL
gentamicin	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Lipofectin®	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
24-well	NULL
plates	NULL
and	NULL
2.5	NULL
x	NULL
10°	NULL
cells/well	NULL
were	NULL
grown	NULL
overnight	NULL
to	NULL
40-60	NULL
%	NULL
confluency	NULL
.	NULL

Subsequently	NULL
,	NULL
0.6	NULL
ug	NULL
of	NULL
expression	NULL
plasmid	NULL
and	NULL
0.2	NULL
4g	NULL
of	NULL
reporter	NULL
plasmid	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
serum-free	NULL
medium	NULL
(	NULL
Optimem	NULL
;	NULL
Gibco	NULL
BRL	NULL
)	NULL
containing	NULL
5	NULL
wl	NULL
of	NULL
Lipofectin®	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

The	NULL
transfection	NULL
mixture	NULL
was	NULL
removed	NULL
after	NULL
24	NULL
h	NULL
and	NULL
replaced	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
serum-containing	NULL
medium	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
a	NULL
further	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
and	NULL
harvested	NULL
into	NULL
80	NULL
l	NULL
of	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
frozen	NULL
at	NULL
-70	NULL
°C	NULL
for	NULL
>	NULL
30	NULL
min	NULL
.	NULL

A	NULL
sample	NULL
(	NULL
20	NULL
wl	NULL
)	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
100	NULL
wl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
a	NULL
MicroLumat	NULL
LB96D	NULL
luminometer	NULL
(	NULL
EG	NULL
&	NULL
G	NULL
;	NULL
Berthold	NULL
,	NULL
Pforzheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
every	NULL
combination	NULL
of	NULL
expression	NULL
and	NULL
reporter	NULL
plasmids	NULL
was	NULL
co-transfected	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
experiments	NULL
were	NULL
independently	NULL
repeated	NULL
two	NULL
or	NULL
three	NULL
times	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
the	NULL
mean	NULL
values	NULL
for	NULL
each	NULL
experiment	NULL
normalized	NULL
to	NULL
the	NULL
values	NULL
obtained	NULL
after	NULL
co-transfection	NULL
with	NULL
reporter	NULL
plasmid	NULL
and	NULL
empty	NULL
expression	NULL
plasmid	NULL
.	NULL

SDS/PAGE	NULL
and	NULL
Western-blot	NULL
analysis	NULL
SDS/PAGE	NULL
and	NULL
electroblotting	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
[	NULL
24	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
reporter	NULL
lysis	NULL
buffer	NULL
lysate	NULL
from	NULL
transfected	NULL
cells	NULL
(	NULL
see	NULL
above	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
SDS	NULL
loading	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
separated	NULL
by	NULL
SDS	NULL
/	NULL
PAGE	NULL
(	NULL
12	NULL
%	NULL
gel	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
on	NULL
to	NULL
a	NULL
Hybond-C	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
,	NULL
which	NULL
was	NULL
blocked	NULL
in	NULL
5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
skimmed	NULL
milk	NULL
in	NULL
PBST	NULL
[	NULL
0.05	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Tween	NULL
in	NULL
PBS	NULL
]	NULL
for	NULL
30	NULL
min	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
5	NULL
min	NULL
each	NULL
time	NULL
in	NULL
PBST	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
1:2000	NULL
dilution	NULL
of	NULL
a	NULL
mouse	NULL
anti-mye	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
in	NULL
PBST	NULL
and	NULL
then	NULL
washed	NULL
as	NULL
before	NULL
.	NULL

The	NULL
secondary	NULL
antibody	NULL
,	NULL
a	NULL
rabbit	NULL
anti-mouse	NULL
horseradish	NULL
peroxidase	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
diluted	NULL
1:3750	NULL
in	NULL
PBST	NULL
,	NULL
was	NULL
added	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
removed	NULL
by	NULL
washing	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
antibody-protein	NULL
complexes	NULL
by	NULL
luminescence	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ECL®	NULL
kit	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

RESULTS	NULL
E-boxes	NULL
in	NULL
x	NULL
promoters	NULL
The	NULL
regulation	NULL
of	NULL
Ig	NULL
transcription	NULL
using	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
as	NULL
a	NULL
model	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
has	NULL
been	NULL
studied	NULL
previously	NULL
[	NULL
9,10,18	NULL
]	NULL
.	NULL

This	NULL
mouse	NULL
x	NULL
promoter	NULL
contains	NULL
an	NULL
octamer	NULL
element	NULL
[	NULL
3,25	NULL
]	NULL
with	NULL
a	NULL
one-base	NULL
mismatch	NULL
from	NULL
the	NULL
consensus	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
compensated	NULL
for	NULL
by	NULL
octamer	NULL
flanking	NULL
nucleotides	NULL
[	NULL
26,27	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
octamer-dependent	NULL
,	NULL
positive	NULL
transcriptional-control	NULL
elements	NULL
are	NULL
found	NULL
5	NULL
and	NULL
3	NULL
'	NULL
of	NULL
the	NULL
octamer	NULL
.	NULL

Functionally	NULL
these	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
three	NULL
regions	NULL
:	NULL
the	NULL
pd-	NULL
«	NULL
Y	NULL
region	NULL
,	NULL
the	NULL
CCCT	NULL
motif	NULL
and	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
.	NULL

The	NULL
pd-	NULL
«	NULL
Y	NULL
region	NULL
contains	NULL
three	NULL
protein	NULL
binding	NULL
motifs	NULL
:	NULL
an	NULL
E-box	NULL
of	NULL
the	NULL
E2A	NULL
type	NULL
,	NULL
an	NULL
A-T-rich	NULL
region	NULL
[	NULL
3	NULL
]	NULL
and	NULL
the	NULL
«	NULL
Y	NULL
element	NULL
[	NULL
28,29	NULL
]	NULL
.	NULL

These	NULL
three	NULL
elements	NULL
stimulate	NULL
octamer-induced	NULL
transcription	NULL
in	NULL
concert	NULL
,	NULL
since	NULL
a	NULL
mutation	NULL
in	NULL
any	NULL
of	NULL
the	NULL
elements	NULL
obliterates	NULL
the	NULL
positive	NULL
effect	NULL
of	NULL
the	NULL
whole	NULL
region	NULL
[	NULL
16	NULL
]	NULL
.	NULL

The	NULL
CCCT	NULL
motif	NULL
and	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
independently	NULL
stimulate	NULL
octamer-dependent	NULL
transcription	NULL
[	NULL
10,18	NULL
]	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
various	NULL
subregions	NULL
of	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
is	NULL
summarized	NULL
in	NULL
Figure	NULL
1	NULL
(	NULL
B	NULL
)	NULL
.	NULL

With	NULL
the	NULL
advent	NULL
of	NULL
sequence	NULL
information	NULL
from	NULL
the	NULL
human	NULL
«	NULL
locus	NULL
[	NULL
2	NULL
]	NULL
,	NULL
it	NULL
became	NULL
evident	NULL
that	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
represents	NULL
a	NULL
composite	NULL
of	NULL
a	NULL
typical	NULL
human	NULL
Vx	NULL
I	NULL
and	NULL
a	NULL
Vx	NULL
II	NULL
subgroup	NULL
promoter	NULL
[	NULL
4	NULL
]	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
pd	NULL
element	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
Transcription	NULL
factor	NULL
AP-4	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
x	NULL
promoter	NULL
E-boxes	NULL
433	NULL
Oct-1/0ct-2	NULL
EBF	NULL
2	NULL
ElA	NULL
pentadecamer	NULL
(	NULL
pd	NULL
)	NULL
xeY	NULL
Octamer	NULL
CCct	NULL
3	NULL
``	NULL
E-box	NULL
TATA	NULL
element	NULL
AACAGCTGTGTAATT	NULL
GCACAGCTGCTC	NULL
E-box	NULL
.	NULL

A-T	NULL
rich	NULL
E-box	NULL
A	NULL
B	NULL
B	NULL
Constructs	NULL
Activity	NULL
-	NULL
Ref	NULL
[	NULL
pd	NULL
|__|	NULL
ey	NULL
}	NULL
-|_	NULL
gctamer	NULL
_	NULL
]	NULL
A	NULL
|	NULL
B	NULL
[	NULL
Tata	NULL
|	NULL
+-+444	NULL
(	NULL
@	NULL
.	NULL

10	NULL
)	NULL
[	NULL
____pra	NULL
__|	NULL
[	NULL
y	NULL
]	NULL
[	NULL
____a	NULL
__|	NULL
_s	NULL
_	NULL
[	NULL
ram	NULL
)	NULL
-	NULL
®	NULL
Octamer	NULL
Tata	NULL
+	NULL
-	NULL
(	NULL
8	NULL
(	NULL
--	NULL
--	NULL
I	NULL
T	NULL
]	NULL
+44	NULL
[	NULL
_	NULL
Octamer	NULL
|	NULL
___	NULL
A	NULL
___|	NULL
+++	NULL
(	NULL
s	NULL
)	NULL
Octamer	NULL
B	NULL
+++	NULL
(	NULL
a	NULL
)	NULL
[	NULL
pa-bormut	NULL
|__|	NULL
-v	NULL
|	NULL
+	NULL
_	NULL
08	NULL
AACeGCTGTGTAATT	NULL
C	NULL
Vx	NULL
gene	NULL
subgroups/families	NULL
Conserved	NULL
E-boxes	NULL
in	NULL
x	NULL
promoters	NULL
HIL	NULL
,	NULL
M9	NULL
,	NULL
M10	NULL
,	NULL
M11	NULL
,	NULL
M12/13	NULL
C	NULL
A	NULL
@	NULL
C	NULL
C	NULL
T	NULL
G	NULL
HIll	NULL
_C	NULL
A	NULL
G	NULL
C	NULL
T	NULL
G..	NULL
HIV	NULL
,	NULL
MB	NULL
,	NULL
M19/28	NULL
..C	NULL
aA	NULL
G	NULL
GCT	NULL
a..	NULL
HV	NULL
,	NULL
M20	NULL
C	NULL
aA	NULL
G	NULL
Cc	NULL
T	NULL
@	NULL
HVII	NULL
,	NULL
M21	NULL
C	NULL
A	NULL
G	NULL
G	NULL
T	NULL
G	NULL
Figure	NULL
1	NULL
-	NULL
Schematic	NULL
Hlustrations	NULL
of	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
and	NULL
conservation	NULL
of	NULL
E-boxes	NULL
In	NULL
x	NULL
promoters	NULL
(	NULL
A	NULL
)	NULL
The	NULL
elements	NULL
important	NULL
for	NULL
promoter	NULL
function	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
interacting	NULL
with	NULL
them	NULL
are	NULL
shown	NULL
.	NULL

Abbreviations	NULL
:	NULL
CBF-A	NULL
,	NULL
CarG-box	NULL
binding	NULL
factor-A	NULL
;	NULL
EBF	NULL
,	NULL
early	NULL
B-cell	NULL
factor	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
different	NULL
promoter	NULL
constructs	NULL
.	NULL

Ref	NULL
,	NULL
reference	NULL
.	NULL

(	NULL
C	NULL
)	NULL
E-box	NULL
sequences	NULL
are	NULL
conserved	NULL
in	NULL
human	NULL
(	NULL
H	NULL
)	NULL
and	NULL
muring	NULL
(	NULL
M	NULL
)	NULL
x	NULL
promoters	NULL
.	NULL

Various	NULL
human	NULL
and	NULL
muring	NULL
V	NULL
subgroups	NULL
and	NULL
families	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
conserved	NULL
E-box	NULL
core	NULL
consensus	NULL
sequences	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

The	NULL
sequences	NULL
shown	NULL
in	NULL
bold	NULL
typeface	NULL
represent	NULL
putative	NULL
AP-4	NULL
binding	NULL
sites	NULL
.	NULL

Vk	NULL
I	NULL
promoters	NULL
,	NULL
whereas	NULL
the	NULL
CCCT	NULL
element	NULL
is	NULL
conserved	NULL
in	NULL
Vx	NULL
II	NULL
promoters	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
E-boxes	NULL
in	NULL
x	NULL
promoters	NULL
are	NULL
well	NULL
conserved	NULL
,	NULL
both	NULL
with	NULL
regard	NULL
to	NULL
sequence	NULL
(	NULL
5-CAGCTG-3	NULL
'	NULL
;	NULL
Figure	NULL
1C	NULL
)	NULL
and	NULL
to	NULL
their	NULL
position	NULL
relative	NULL
to	NULL
the	NULL
octamer	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
[	NULL
4	NULL
]	NULL
.	NULL

Given	NULL
that	NULL
the	NULL
E-boxes	NULL
in	NULL
x	NULL
promoters	NULL
show	NULL
this	NULL
high	NULL
degree	NULL
of	NULL
conservation	NULL
and	NULL
functional	NULL
activity	NULL
,	NULL
we	NULL
favour	NULL
the	NULL
view	NULL
that	NULL
they	NULL
are	NULL
relevant	NULL
transcriptional	NULL
control	NULL
elements	NULL
for	NULL
developmentally	NULL
regulated	NULL
Ig	NULL
expression	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
AP-4	NULL
and	NULL
E47	NULL
bind	NULL
to	NULL
the	NULL
SPG	NULL
x	NULL
promoter	NULL
pd	NULL
element	NULL
We	NULL
have	NULL
noted	NULL
previously	NULL
that	NULL
,	NULL
although	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
E-boxes	NULL
are	NULL
candidate	NULL
targets	NULL
for	NULL
£24	NULL
gene	NULL
products	NULL
,	NULL
the	NULL
results	NULL
of	NULL
an	NULL
investigation	NULL
of	NULL
the	NULL
relevant	NULL
interaction	NULL
using	NULL
nuclear	NULL
extracts	NULL
were	NULL
ambiguous	NULL
[	NULL
18	NULL
]	NULL
.	NULL

Since	NULL
the	NULL
pd-E-box	NULL
sequence	NULL
5-CAGCTG-3	NULL
'	NULL
is	NULL
also	NULL
a	NULL
putative	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
bHLH-Zip	NULL
protein	NULL
AP4	NULL
[	NULL
20	NULL
]	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
E47	NULL
and/or	NULL
AP-4	NULL
to	NULL
bind	NULL
the	NULL
pd	NULL
element	NULL
in	NULL
vitro	NULL
was	NULL
investigated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
A	NULL
)	NULL
,	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
AP-4	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
pd	NULL
element	NULL
probe	NULL
,	NULL
a	NULL
complex	NULL
was	NULL
formed	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
AP-4	NULL
complex	NULL
was	NULL
pd	NULL
wE5	NULL
__	NULL
pdE-box	NULL
pda-T	NULL
3	NULL
mut	NULL
mut	NULL
E-box	NULL
mr	NULL
``	NULL
)	NULL
Lr	NULL
]	NULL
i=	NULL
``	NULL
lysate	NULL
lysate	NULL
APA	NULL
________________	NULL
.	NULL

#	NULL
000	NULL
.	NULL

09	NULL
>	NULL
¥-Bs	NULL
--	NULL
~	NULL
pd	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
§	NULL
7	NULL
a	NULL
8	NULL
10	NULL
1	NULL
12	NULL
3	NULL
14	NULL
15	NULL
16	NULL
B	NULL
pd	NULL
pdE-box	NULL
|	NULL
wE5	NULL
|	NULL
pdpes	NULL
a	NULL
mut	NULL
a	NULL
me	NULL
Nae	NULL
J	NULL
eet	NULL
]	NULL
ine	NULL
4	NULL
ear	NULL
<	NULL
-	NULL
E47	NULL
«	NULL
t-	NULL
pd	NULL
1	NULL
2	NULL
3	NULL
a	NULL
5	NULL
6	NULL
y	NULL
a	NULL
8	NULL
10	NULL
C	NULL
pd	NULL
TACTCTCAAAGAGCTGTGTAATTTACTICC	NULL
3	NULL
``	NULL
pdE-boxmut	NULL
5'-	NULL
TACTCTCAAACGCTGTGTAATTTACTTCC	NULL
-3	NULL
§'-	NULL
TACTCTCAAAGAGCTGTGTeqTTTACTTCC	NULL
-3*	NULL
Es	NULL
5'-	NULL
TCTGCTGCAGGTGTTCTGTCT	NULL
-3	NULL
``	NULL
pduE5	NULL
5'-	NULL
TACTCTCAAACAGGTGTGTAATTTACTTCC	NULL
3	NULL
3	NULL
'	NULL
E-box	NULL
5'-	NULL
ATCTCAAGCCAGCACAGCTGCTCATGATCTAGGTG	NULL
-3	NULL
'	NULL
Octamer	NULL
§'-	NULL
GATCTCAAGTGATTTGCATCGCATGAGACG-3	NULL
'	NULL
Figure	NULL
2	NULL
-	NULL
Both	NULL
AP-4	NULL
and	NULL
E47	NULL
bind	NULL
the	NULL
pd-element	NULL
E-box	NULL
In	NULL
EMSA	NULL
(	NULL
A	NULL
)	NULL
Binding	NULL
of	NULL
AP-4	NULL
,	NULL
translated	NULL
/n	NULL
vifro	NULL
,	NULL
to	NULL
a	NULL
radiolabelled	NULL
pd	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
{	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
unlabelled	NULL
competitors	NULL
as	NULL
indicated	NULL
(	NULL
lanes	NULL
3-8	NULL
and	NULL
11-16	NULL
)	NULL
.	NULL

Competitors	NULL
were	NULL
added	NULL
at	NULL
100-	NULL
and	NULL
1000-fold	NULL
molar	NULL
excess	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
9	NULL
contain	NULL
reticulocyte	NULL
lysate	NULL
without	NULL
template	NULL
DNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
it	NULL
vifro-translated	NULL
E47	NULL
to	NULL
a	NULL
radiolabelled	NULL
pd	NULL
probe	NULL
,	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
G	NULL
)	NULL
Sequences	NULL
of	NULL
the	NULL
sense	NULL
strands	NULL
of	NULL
the	NULL
different	NULL
oligonucleotides	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

E-box	NULL
core	NULL
sequences	NULL
are	NULL
shown	NULL
underlined	NULL
.	NULL

Mutated	NULL
nucleotides	NULL
are	NULL
indicated	NULL
by	NULL
lowercase	NULL
letters	NULL
.	NULL

effectively	NULL
removed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
pd	NULL
element	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
by	NULL
a	NULL
pd	NULL
element	NULL
with	NULL
a	NULL
mutated	NULL
A-T-rich	NULL
region	NULL
(	NULL
pdA-Tmut	NULL
;	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
pd	NULL
element	NULL
carrying	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
E-box	NULL
(	NULL
pdE-box	NULL
mut	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
failed	NULL
to	NULL
compete	NULL
,	NULL
as	NULL
did	NULL
the	NULL
4E5	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
the	NULL
octamer	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
pd-region	NULL
E-box	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
whether	NULL
the	NULL
E-box	NULL
present	NULL
in	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
3'-region	NULL
interacted	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
.	NULL

This	NULL
was	NULL
indeed	NULL
the	NULL
case	NULL
,	NULL
since	NULL
an	NULL
unlabelled	NULL
3	NULL
``	NULL
-region	NULL
oligonucleotide	NULL
also	NULL
competed	NULL
with	NULL
the	NULL
AP-4	NULL
complex	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
434	NULL
A.	NULL
Aranburu	NULL
and	NULL
others	NULL
The	NULL
pd-element	NULL
E-box	NULL
was	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
also	NULL
a	NULL
target	NULL
for	NULL
in	NULL
vitro	NULL
translated	NULL
E47	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

A	NULL
complex	NULL
formed	NULL
with	NULL
E47	NULL
and	NULL
labelled	NULL
pd	NULL
probe	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
was	NULL
efficiently	NULL
removed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
pd	NULL
element	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
pdE-box	NULL
mut	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
wE5	NULL
oligonucleotide	NULL
(	NULL
a	NULL
known	NULL
target	NULL
for	NULL
binding	NULL
by	NULL
E47	NULL
[	NULL
30	NULL
]	NULL
)	NULL
was	NULL
at	NULL
least	NULL
as	NULL
good	NULL
a	NULL
competitor	NULL
as	NULL
the	NULL
pd	NULL
element	NULL
itself	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
and	NULL
so	NULL
was	NULL
a	NULL
composite	NULL
oligonucleotide	NULL
,	NULL
pd-uE5	NULL
,	NULL
containing	NULL
the	NULL
wES-motif	NULL
and	NULL
the	NULL
flanking	NULL
sequences	NULL
from	NULL
the	NULL
pd	NULL
element	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
E47	NULL
translated	NULL
in	NULL
vitro	NULL
has	NULL
affinity	NULL
for	NULL
both	NULL
the	NULL
pd-element	NULL
E-box	NULL
as	NULL
well	NULL
as	NULL
the	NULL
yE5	NULL
motif	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
interaction	NULL
appeared	NULL
to	NULL
reside	NULL
in	NULL
the	NULL
E-box	NULL
core	NULL
sequence	NULL
and	NULL
not	NULL
in	NULL
the	NULL
flanking	NULL
regions	NULL
(	NULL
compare	NULL
4E5	NULL
with	NULL
pd-4E5	NULL
)	NULL
.	NULL

AP-4	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
showed	NULL
a	NULL
strong	NULL
preference	NULL
for	NULL
the	NULL
pd-E-box	NULL
,	NULL
although	NULL
it	NULL
also	NULL
bound	NULL
the	NULL
E5	NULL
oligonucleotide	NULL
when	NULL
it	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AP-4	NULL
,	NULL
but	NULL
not	NULL
E47	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
pd	NULL
element	NULL
in	NULL
nuclear	NULL
extracts	NULL
Having	NULL
established	NULL
that	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
and	NULL
E47	NULL
have	NULL
affinity	NULL
for	NULL
SP6	NULL
x	NULL
promoter	NULL
E-boxes	NULL
we	NULL
then	NULL
investigated	NULL
whether	NULL
the	NULL
pd	NULL
element	NULL
was	NULL
bound	NULL
by	NULL
either	NULL
AP-4	NULL
or	NULL
E47	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
a	NULL
series	NULL
of	NULL
gel	NULL
retardation	NULL
experiments	NULL
,	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
non-lymphoid	NULL
(	NULL
HeLa	NULL
)	NULL
and	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
Raji	NULL
,	NULL
Namalwa	NULL
and	NULL
BJAB	NULL
)	NULL
,	NULL
were	NULL
performed	NULL
.	NULL

Figure	NULL
3	NULL
(	NULL
A	NULL
)	NULL
shows	NULL
the	NULL
results	NULL
obtained	NULL
using	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
with	NULL
the	NULL
pd	NULL
element	NULL
as	NULL
a	NULL
probe	NULL
;	NULL
two	NULL
major	NULL
gel-retarded	NULL
complexes	NULL
were	NULL
observed	NULL
.	NULL

The	NULL
higher	NULL
mobility	NULL
band	NULL
corresponds	NULL
to	NULL
CArG-box	NULL
binding	NULL
factor-A	NULL
[	NULL
31	NULL
]	NULL
,	NULL
whereas	NULL
the	NULL
lower	NULL
mobility	NULL
band	NULL
showed	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
competition	NULL
as	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
when	NULL
using	NULL
the	NULL
same	NULL
set	NULL
of	NULL
competitors	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unlabelled	NULL
pd	NULL
element	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
the	NULL
pdA-T	NULL
mut	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
or	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
inhibited	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
.	NULL

Neither	NULL
pdE-box	NULL
mut	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
nor	NULL
the	NULL
octamer	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
prevented	NULL
formation	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
,	NULL
whereas	NULL
zE5	NULL
competed	NULL
slightly	NULL
for	NULL
complex	NULL
formation	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
strongly	NULL
inhibited	NULL
complex	NULL
formation	NULL
between	NULL
in	NULL
vitro	NULL
translated	NULL
E47	NULL
and	NULL
the	NULL
pd	NULL
element	NULL
probe	NULL
,	NULL
whereas	NULL
this	NULL
was	NULL
not	NULL
the	NULL
case	NULL
when	NULL
using	NULL
in	NULL
vitro	NULL
translated	NULL
AP4	NULL
(	NULL
compare	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
and	NULL
Figure	NULL
2A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Namalwa	NULL
,	NULL
BJAB	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
unequivocally	NULL
identify	NULL
the	NULL
pd-element	NULL
binding	NULL
factor	NULL
,	NULL
the	NULL
specific	NULL
complex	NULL
was	NULL
further	NULL
analysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-bodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
(	NULL
B	NULL
)	NULL
,	NULL
a	NULL
polyclonal	NULL
antibody	NULL
against	NULL
AP-4	NULL
[	NULL
17	NULL
]	NULL
prevented	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
,	NULL
whereas	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
E47	NULL
did	NULL
not	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
both	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
and	NULL
E47	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
site	NULL
,	NULL
but	NULL
only	NULL
AP-4	NULL
appeared	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
complex	NULL
formation	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
we	NULL
next	NULL
addressed	NULL
the	NULL
question	NULL
whether	NULL
E47	NULL
was	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
preparations	NULL
.	NULL

The	NULL
E5	NULL
probe	NULL
with	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
as	NULL
a	NULL
source	NULL
of	NULL
protein	NULL
was	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
(	NULL
C	NULL
)	NULL
,	NULL
three	NULL
gel-retarded	NULL
complexes	NULL
were	NULL
obtained	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
antibodies	NULL
against	NULL
E47	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
AP-4	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
slower	NULL
migrating	NULL
complex	NULL
contained	NULL
E47	NULL
,	NULL
whereas	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
contained	NULL
AP-4	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
data	NULL
that	NULL
AP-4	NULL
is	NULL
the	NULL
preferred	NULL
pd-element	NULL
ligand	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E47	NULL
,	NULL
which	NULL
has	NULL
an	NULL
intrinsic	NULL
affinity	NULL
for	NULL
the	NULL
pd-element	NULL
E-box	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

AP-4	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
in	NULL
the	NULL
SPG	NULL
x	NULL
promoter	NULL
Figures	NULL
2	NULL
(	NULL
A	NULL
)	NULL
and	NULL
3	NULL
(	NULL
A	NULL
)	NULL
show	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
oligonucleotide	NULL
inhibited	NULL
binding	NULL
of	NULL
AP-4	NULL
to	NULL
the	NULL
pd	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
A	NULL
pd	NULL
LES	NULL
-	NULL
pdE-box	NULL
pdA-T	NULL
3°	NULL
Octamer	NULL
mut	NULL
mut	NULL
E-box	NULL
P	NULL
met	NULL
[	NULL
P	NULL
Cant	NULL
HO	NULL
oath	NULL
|	NULL
a==7	NULL
_-	NULL
)	NULL
__	NULL
Rall	NULL
|	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
_	NULL
Raji	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
«	NULL
b	NULL
do	NULL
--	NULL
ar-1	NULL
.-	NULL
«	NULL
s	NULL
10	NULL
R	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
0	NULL
9	NULL
10	NULL
ff	NULL
12	NULL
93	NULL
14	NULL
B	NULL
C	NULL
o-AP4	NULL
a	NULL
Torm	NULL
-	NULL
]	NULL
&	NULL
%	NULL
d	NULL
Poa	NULL
&	NULL
4	NULL
&	NULL
Raji	NULL
Raji	NULL
«	NULL
«	NULL
»	NULL
aun	NULL
«	NULL
*	NULL
«	NULL
#	NULL
6	NULL
«	NULL
g-	NULL
E47	NULL
«	NULL
l-	NULL
AP-4	NULL
Figure	NULL
3	NULL
_	NULL
AP-4	NULL
,	NULL
but	NULL
not	NULL
E47	NULL
,	NULL
binds	NULL
the	NULL
pd-element	NULL
E-box	NULL
In	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
the	NULL
Rajl	NULL
cell	NULL
line	NULL
(	NULL
A	NULL
)	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Raji	NULL
(	NULL
human	NULL
B-cell	NULL
lymphoma	NULL
)	NULL
cell	NULL
ling	NULL
as	NULL
a	NULL
source	NULL
of	NULL
protein	NULL
and	NULL
a	NULL
radiolabelled	NULL
pd-element	NULL
probe	NULL
.	NULL

Various	NULL
unlabelled	NULL
competitors	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
were	NULL
added	NULL
in	NULL
100-	NULL
and	NULL
1000-fold	NULL
molar	NULL
excess	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
performed	NULL
with	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
a	NULL
pd-element	NULL
probe	NULL
{	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
and	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
AP-4	NULL
(	NULL
«	NULL
x-AP4	NULL
;	NULL
lanes	NULL
2-4	NULL
,	NULL
antibody	NULL
diluted	NULL
1:10	NULL
,	NULL
1:5	NULL
,	NULL
1:2	NULL
respectively	NULL
)	NULL
or	NULL
E47	NULL
(	NULL
«	NULL
-E47	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
as	NULL
a	NULL
source	NULL
of	NULL
protein	NULL
and	NULL
a	NULL
radiolabelled	NULL
E5	NULL
probe	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
nuclear	NULL
extract	NULL
contains	NULL
E47	NULL
.	NULL

Lane	NULL
1	NULL
shows	NULL
the	NULL
three	NULL
gel-retarded	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
probe	NULL
;	NULL
the	NULL
lower	NULL
mobility	NULL
band	NULL
was	NULL
absent	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
anti-E47	NULL
antibody	NULL
(	NULL
x-E47	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
highest	NULL
mobility	NULL
band	NULL
was	NULL
removed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
AP-4	NULL
antibody	NULL
(	NULL
x-AP4	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

probe	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
3	NULL
'	NULL
E-box	NULL
might	NULL
also	NULL
be	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
AP-4	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
this	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
human	NULL
B-cell	NULL
lymphoma	NULL
nuclear	NULL
extracts	NULL
and	NULL
a	NULL
labelled	NULL
3	NULL
'	NULL
E-box	NULL
probe	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Two	NULL
complexes	NULL
were	NULL
formed	NULL
,	NULL
a	NULL
specific	NULL
low-mobility	NULL
band	NULL
and	NULL
an	NULL
non-specific	NULL
band	NULL
with	NULL
higher	NULL
mobility	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
3	NULL
'	NULL
E-box	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
by	NULL
the	NULL
pd	NULL
element	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
addition	NULL
of	NULL
4E5	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
pdE-boxmut	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
the	NULL
octamer	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
.	NULL

The	NULL
low-mobility	NULL
band	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
AP-4	NULL
,	NULL
since	NULL
its	NULL
formation	NULL
was	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
anti-AP-4	NULL
antibody	NULL
(	NULL
Figure	NULL
4B	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
anti-E47	NULL
antibody	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
AP-4	NULL
also	NULL
is	NULL
the	NULL
preferred	NULL
ligand	NULL
for	NULL
the	NULL
SP6	NULL
k	NULL
3	NULL
E-box	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-4	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
x	NULL
promoter	NULL
E-boxes	NULL
435	NULL
A	NULL
&	NULL
3	NULL
E	NULL
®	NULL
x	NULL
a	NULL
3	NULL
pd	NULL
_	NULL
ues	NULL
§	NULL
g	NULL
E-box	NULL
w-	NULL
£	NULL
Raji	NULL
#	NULL
``	NULL
®®	NULL
#	NULL
B	NULL
wo	NULL
--	NULL
aP-4	NULL
«	NULL
#	NULL
-3	NULL
``	NULL
E-box	NULL
B	NULL
a-AP4	NULL
m	NULL
n	NULL
ﬂ	NULL
$	NULL
5	NULL
Raji	NULL
.	NULL

dim	NULL
ae	NULL
<	NULL
G-AP-4	NULL
«	NULL
«	NULL
-	NULL
3	NULL
``	NULL
E-box	NULL
Figure	NULL
4	NULL
-	NULL
AP-4	NULL
binds	NULL
the	NULL
E-box	NULL
present	NULL
In	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
3	NULL
'	NULL
region	NULL
:	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Rajl	NULL
cell	NULL
line	NULL
and	NULL
radiolabelled	NULL
3	NULL
'	NULL
E-box	NULL
probe	NULL
(	NULL
A	NULL
)	NULL
The	NULL
lower	NULL
mobility	NULL
band	NULL
was	NULL
removed	NULL
by	NULL
addition	NULL
of	NULL
a	NULL
200-	NULL
or	NULL
1000-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
3	NULL
``	NULL
E-box	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
pd	NULL
element	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
same	NULL
concentration	NULL
of	NULL
the	NULL
E5	NULL
element	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
to	NULL
the	NULL
template	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
manner	NULL
,	NULL
a	NULL
1000-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
pd	NULL
element	NULL
with	NULL
a	NULL
disrupted	NULL
E-box	NULL
(	NULL
pdE-boxmut	NULL
;	NULL
lane	NULL
8	NULL
)	NULL
and	NULL
the	NULL
octamer	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
failed	NULL
to	NULL
compete	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
with	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
3	NULL
``	NULL
E-box	NULL
probe	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
and	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
AP-4	NULL
antibody	NULL
(	NULL
c-AP4	NULL
;	NULL
lanes	NULL
2-4	NULL
,	NULL
antibody	NULL
diluted	NULL
1:10	NULL
,	NULL
1:5	NULL
,	NULL
1:2	NULL
respectively	NULL
)	NULL
,	NULL
or	NULL
an	NULL
antibody	NULL
against	NULL
E47	NULL
(	NULL
a-E47	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

AP-4	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
murine	NULL
B-cell	NULL
lines	NULL
binds	NULL
to	NULL
the	NULL
pd	NULL
element	NULL
The	NULL
antibody	NULL
against	NULL
AP-4	NULL
was	NULL
raised	NULL
against	NULL
the	NULL
human	NULL
AP-4	NULL
protein	NULL
[	NULL
17	NULL
]	NULL
,	NULL
and	NULL
therefore	NULL
all	NULL
our	NULL
initial	NULL
experiments	NULL
were	NULL
made	NULL
using	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
human	NULL
B-cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
(	NULL
G	NULL
EC	NULL
obs	NULL
%	NULL
.	NULL

#	NULL
``	NULL
1	NULL
,	NULL
I	NULL
``	NULL
<	NULL
-	NULL
CBF-A	NULL
IVT	NULL
AP-4	NULL
5194	NULL
a-AP4	NULL
o-E47	NULL
-	NULL
<	NULL
s-	NULL
pd	NULL
Figure	NULL
5	NULL
Complex	NULL
between	NULL
AP-4	NULL
translated	NULL
in	NULL
vifre	NULL
and	NULL
a	NULL
pd	NULL
element	NULL
probe	NULL
has	NULL
similar	NULL
mobility	NULL
to	NULL
the	NULL
complex	NULL
detected	NULL
In	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Rajl	NULL
and	NULL
$	NULL
194	NULL
cell	NULL
lines	NULL
EMSA	NULL
using	NULL
the	NULL
pd	NULL
element	NULL
as	NULL
a	NULL
probe	NULL
with	NULL
AP-4	NULL
translated	NULL
/n	NULL
vifro	NULL
(	NULL
IVT	NULL
AP-4	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Raji	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
$	NULL
194	NULL
cell	NULL
lings	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
antibodies	NULL
against	NULL
AP-4	NULL
(	NULL
z-AP4	NULL
)	NULL
or	NULL
E47	NULL
(	NULL
a-E47	NULL
)	NULL
respectively	NULL
were	NULL
added	NULL
.	NULL

since	NULL
our	NULL
model	NULL
promoter	NULL
is	NULL
the	NULL
murine	NULL
SP6	NULL
x	NULL
promoter	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
for	NULL
complex	NULL
formation	NULL
using	NULL
the	NULL
pd	NULL
element	NULL
and	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
the	NULL
murine	NULL
lymphoid	NULL
cell	NULL
lines	NULL
K46R	NULL
(	NULL
a	NULL
B-cell	NULL
lymphoma	NULL
)	NULL
and	NULL
$	NULL
194	NULL
(	NULL
a	NULL
plasmacytoma	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
primary	NULL
LPS-stimulated	NULL
murine	NULL
spleen	NULL
cells	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
an	NULL
EMSA	NULL
using	NULL
the	NULL
$	NULL
194	NULL
plasmacytoma	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
complex	NULL
was	NULL
detected	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
with	NULL
similar	NULL
electrophoretic	NULL
mobility	NULL
to	NULL
the	NULL
complex	NULL
formed	NULL
using	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
and	NULL
to	NULL
that	NULL
formed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
human	NULL
Raji	NULL
cell	NULL
line	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
$	NULL
194	NULL
complex	NULL
was	NULL
removed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
anti-AP-4	NULL
antibody	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
anti-E47	NULL
antibody	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
K46R	NULL
and	NULL
LPS-stimulated	NULL
spleen	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
AP-4	NULL
,	NULL
and	NULL
not	NULL
E47	NULL
or	NULL
any	NULL
other	NULL
bHLH	NULL
protein	NULL
,	NULL
was	NULL
the	NULL
preferred	NULL
protein	NULL
interacting	NULL
with	NULL
the	NULL
pd	NULL
element	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Ectopically	NULL
expressed	NULL
AP-4	NULL
does	NULL
not	NULL
transactivate	NULL
a	NULL
pd-element	NULL
reporter	NULL
construct	NULL
AP-4	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
an	NULL
SV40	NULL
enhancer	NULL
binding	NULL
factor	NULL
capable	NULL
of	NULL
stimulating	NULL
SV40	NULL
transcription	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
several	NULL
viral	NULL
and	NULL
cellular	NULL
enhancers	NULL
.	NULL

However	NULL
,	NULL
not	NULL
much	NULL
is	NULL
known	NULL
about	NULL
the	NULL
function	NULL
of	NULL
AP-4	NULL
in	NULL
promoting	NULL
transcription	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
well-known	NULL
trans-activation	NULL
properties	NULL
of	NULL
E47	NULL
.	NULL

We	NULL
wanted	NULL
to	NULL
compare	NULL
the	NULL
ability	NULL
of	NULL
AP-4	NULL
and	NULL
E47	NULL
to	NULL
transactivate	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
pd	NULL
element	NULL
as	NULL
a	NULL
regulatory	NULL
element	NULL
.	NULL

We	NULL
therefore	NULL
made	NULL
a	NULL
reporter	NULL
plasmid	NULL
carrying	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
pd	NULL
element	NULL
linked	NULL
to	NULL
the	NULL
c-fos	NULL
minimal	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

This	NULL
reporter	NULL
was	NULL
transiently	NULL
co-transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
,	NULL
together	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
436	NULL
A.	NULL
Aranburu	NULL
and	NULL
others	NULL
A	NULL
o	NULL
a	NULL
200	NULL
-	NULL
I	NULL
A	NULL
c	NULL
5	NULL
,	NULL
5	NULL
50	NULL
_-	NULL
!	NULL

0	NULL
s	NULL
€	NULL
-	NULL
40	NULL
_	NULL
3	NULL
6	NULL
*-	NULL
_	NULL
30	NULL
_	NULL
20	NULL
_	NULL
10	NULL
_	NULL
i	NULL
0	NULL
_	NULL
wilm	NULL
P	NULL
som	NULL
___|	NULL
Reporter	NULL
2x	NULL
(	NULL
E2L.E5	NULL
)	NULL
4xpd	NULL
plasmid	NULL
Expression	NULL
E47	NULL
_	NULL
AP-4	NULL
pcDNA3	NULL
-	NULL
E47	NULL
-	NULL
AP-4	NULL
-	NULL
pcDNA3	NULL
plasmid	NULL
B	NULL
126.5	NULL
kDa	NULL
89.4	NULL
kDa	NULL
E47	NULL
+	NULL
g	NULL
«	NULL
enmen	NULL
64.9	NULL
kDa	NULL
AP-4	NULL
>	NULL
#	NULL
#	NULL
(	NULL
-a	NULL
52.8	NULL
kDa	NULL
4xpd	NULL
4xpd	NULL
2x	NULL
(	NULL
uE2uE5	NULL
)	NULL
2x	NULL
(	NULL
uE2uE5	NULL
)	NULL
AP-4	NULL
E47	NULL
p.	NULL
47	NULL
Figure	NULL
6	NULL
Comparison	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
AP-4	NULL
and	NULL
E47	NULL
to	NULL
transactivate	NULL
reporter	NULL
constructs	NULL
carrying	NULL
different	NULL
E-box	NULL
motifs	NULL
as	NULL
regulatory	NULL
elements	NULL
(	NULL
A	NULL
)	NULL
Hela	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
plasmids	NULL
expressing	NULL
either	NULL
AP-4	NULL
or	NULL
E47	NULL
or	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
pcDNA3	NULL
)	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
carrying	NULL
either	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wee-meE5	NULL
sites	NULL
[	NULL
2	NULL
x	NULL
(	NULL
@	NULL
E2.E5	NULL
)	NULL
]	NULL
,	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
fos	NULL
promoter	NULL
or	NULL
a	NULL
multimerized	NULL
pd	NULL
element	NULL
(	NULL
4	NULL
x	NULL
pd	NULL
)	NULL
.	NULL

Fold	NULL
induction	NULL
was	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
level	NULL
of	NULL
luciferase	NULL
expression	NULL
obtained	NULL
with	NULL
pcDNA3	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western-blot	NULL
analysis	NULL
of	NULL
lysates	NULL
used	NULL
to	NULL
measure	NULL
luciferase	NULL
activity	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
Myc-tagged	NULL
AP-4	NULL
is	NULL
expressed	NULL
equally	NULL
well	NULL
as	NULL
the	NULL
Myc-tagged	NULL
E47	NULL
.	NULL

Lysates	NULL
were	NULL
from	NULL
co-transfections	NULL
using	NULL
the	NULL
indicated	NULL
expression	NULL
and	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
a	NULL
Myc	NULL
antibody	NULL
and	NULL
the	NULL
arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
Myc-tagged	NULL
AP-4	NULL
and	NULL
Myc-tagged	NULL
E47	NULL
respectively	NULL
.	NULL

Molecular-mass	NULL
standards	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
Myc-tagged	NULL
versions	NULL
of	NULL
either	NULL
AP-4	NULL
or	NULL
E47	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
AP-4	NULL
and	NULL
E47	NULL
to	NULL
transactivate	NULL
a	NULL
luciferase	NULL
reporter	NULL
carrying	NULL
two	NULL
copies	NULL
each	NULL
of	NULL
the	NULL
4E2	NULL
and	NULL
wE5	NULL
motifs	NULL
as	NULL
regulatory	NULL
element	NULL
was	NULL
also	NULL
analysed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
(	NULL
A	NULL
)	NULL
,	NULL
E47	NULL
transactivated	NULL
the	NULL
pd-construct	NULL
poorly	NULL
(	NULL
about	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
10-fold	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
wE2-uES-construct	NULL
was	NULL
very	NULL
efficiently	NULL
activated	NULL
(	NULL
200-fold	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
AP-4	NULL
did	NULL
not	NULL
transactivate	NULL
any	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
Myc-tagged	NULL
versions	NULL
of	NULL
both	NULL
AP4	NULL
and	NULL
E47	NULL
were	NULL
efficiently	NULL
expressed	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
Figure	NULL
6	NULL
(	NULL
B	NULL
)	NULL
,	NULL
which	NULL
shows	NULL
a	NULL
Western-blot	NULL
of	NULL
the	NULL
same	NULL
lysates	NULL
as	NULL
those	NULL
used	NULL
for	NULL
assaying	NULL
luciferase	NULL
activity	NULL
in	NULL
a	NULL
representative	NULL
transfection	NULL
experiment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
Myc-tagged	NULL
version	NULL
of	NULL
AP-4	NULL
bound	NULL
the	NULL
pd	NULL
probe	NULL
efficiently	NULL
in	NULL
an	NULL
EMSA	NULL
{	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
co-transfection	NULL
experiments	NULL
using	NULL
untagged	NULL
AP-4	NULL
were	NULL
performed	NULL
and	NULL
similar	NULL
results	NULL
to	NULL
those	NULL
where	NULL
the	NULL
Myc-tagged	NULL
version	NULL
was	NULL
used	NULL
were	NULL
obtained	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
we	NULL
conclude	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
pd	NULL
element	NULL
,	NULL
AP-4	NULL
is	NULL
not	NULL
a	NULL
transactivator	NULL
but	NULL
must	NULL
act	NULL
via	NULL
alternate	NULL
mechanisms	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
low	NULL
level	NULL
of	NULL
activation	NULL
induced	NULL
by	NULL
epitope-tagged	NULL
E47	NULL
on	NULL
the	NULL
4x	NULL
pd-reporter	NULL
when	NULL
compared	NULL
with	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
wE2-uE5-construct	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
E47	NULL
being	NULL
excluded	NULL
from	NULL
the	NULL
pd-E-box	NULL
site	NULL
by	NULL
endogenous	NULL
AP-4	NULL
,	NULL
since	NULL
no	NULL
binding	NULL
of	NULL
E47	NULL
to	NULL
the	NULL
pd	NULL
probe	NULL
was	NULL
detected	NULL
in	NULL
EMSAs	NULL
when	NULL
using	NULL
nuclear	NULL
exctracts	NULL
as	NULL
a	NULL
source	NULL
of	NULL
protein	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
E47	NULL
binding	NULL
to	NULL
the	NULL
pd	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
after	NULL
transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
with	NULL
the	NULL
E47	NULL
expression	NULL
plasmid	NULL
,	NULL
whereas	NULL
binding	NULL
to	NULL
the	NULL
wE5	NULL
probe	NULL
was	NULL
readily	NULL
detected	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
our	NULL
goal	NULL
was	NULL
to	NULL
identify	NULL
the	NULL
ligand	NULL
for	NULL
the	NULL
two	NULL
E-boxes	NULL
present	NULL
in	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
.	NULL

Using	NULL
synthetic	NULL
mutant	NULL
or	NULL
wild-type	NULL
pd	NULL
element	NULL
oligonucleotides	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
wild-type	NULL
3	NULL
'	NULL
E-box	NULL
oligonucleotide	NULL
in	NULL
EMSA	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
bHLH-Zip	NULL
protein	NULL
AP-4	NULL
interacts	NULL
in	NULL
a	NULL
specific	NULL
fashion	NULL
with	NULL
both	NULL
E-boxes	NULL
.	NULL

Both	NULL
in	NULL
vitro	NULL
translated	NULL
AP-4	NULL
and	NULL
nuclear-extract-derived	NULL
AP-4	NULL
exhibited	NULL
similar	NULL
competition	NULL
patterns	NULL
and	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
the	NULL
major	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
AP-4	NULL
when	NULL
specific	NULL
antibodies	NULL
were	NULL
used	NULL
.	NULL

Experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
human	NULL
B-cell	NULL
lymphomas	NULL
(	NULL
Raji	NULL
,	NULL
Namalwa	NULL
and	NULL
BJAB	NULL
)	NULL
and	NULL
with	NULL
several	NULL
murine	NULL
cell	NULL
lines	NULL
and	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
the	NULL
E-boxes	NULL
found	NULL
in	NULL
«	NULL
promoters	NULL
are	NULL
putative	NULL
AP-4	NULL
binding	NULL
sites	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
speculated	NULL
that	NULL
the	NULL
original	NULL
x	NULL
gene	NULL
promoter	NULL
contained	NULL
a	NULL
TATA-box	NULL
,	NULL
an	NULL
octamer	NULL
element	NULL
and	NULL
possibly	NULL
an	NULL
E-box	NULL
[	NULL
32	NULL
]	NULL
.	NULL

Since	NULL
the	NULL
latter	NULL
element	NULL
is	NULL
well	NULL
conserved	NULL
in	NULL
x	NULL
promoters	NULL
[	NULL
4	NULL
]	NULL
,	NULL
and	NULL
our	NULL
findings	NULL
show	NULL
that	NULL
AP-4	NULL
binds	NULL
to	NULL
both	NULL
E-boxes	NULL
in	NULL
the	NULL
SP6	NULL
«	NULL
k	NULL
promoter	NULL
,	NULL
we	NULL
would	NULL
like	NULL
to	NULL
propose	NULL
AP-4	NULL
as	NULL
the	NULL
major	NULL
ligand	NULL
for	NULL
xk	NULL
promoter	NULL
E-boxes	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
pd	NULL
element	NULL
is	NULL
a	NULL
weak	NULL
stimulatory	NULL
element	NULL
when	NULL
present	NULL
as	NULL
four	NULL
copies	NULL
in	NULL
a	NULL
minimal	NULL
promoter	NULL
[	NULL
15	NULL
]	NULL
,	NULL
indicating	NULL
that	NULL
none	NULL
of	NULL
the	NULL
pd-element	NULL
ligands	NULL
should	NULL
be	NULL
strong	NULL
transcriptional	NULL
activators	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
SP6	NULL
«	NULL
co-stimulatory	NULL
elements	NULL
is	NULL
octamer-dependent	NULL
,	NULL
precluding	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
strong	NULL
activator	NULL
binding	NULL
to	NULL
any	NULL
of	NULL
these	NULL
sites	NULL
and	NULL
thereby	NULL
overuling	NULL
the	NULL
function	NULL
of	NULL
the	NULL
octamer-binding	NULL
proteins	NULL
.	NULL

This	NULL
functional	NULL
profile	NULL
of	NULL
pd	NULL
interacting	NULL
proteins	NULL
fits	NULL
nicely	NULL
with	NULL
the	NULL
transfection	NULL
data	NULL
shown	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
where	NULL
no	NULL
stimulation	NULL
was	NULL
seen	NULL
with	NULL
AP-4	NULL
but	NULL
the	NULL
potent	NULL
activator	NULL
function	NULL
of	NULL
E47	NULL
disqualified	NULL
it	NULL
as	NULL
a	NULL
pd-element	NULL
ligand	NULL
,	NULL
given	NULL
that	NULL
all	NULL
x	NULL
promoter	NULL
transcription	NULL
should	NULL
be	NULL
octamer-dependent	NULL
[	NULL
6-8,10	NULL
]	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
E47	NULL
showed	NULL
a	NULL
robust	NULL
interaction	NULL
with	NULL
the	NULL
pd	NULL
probe	NULL
in	NULL
EMSAs	NULL
,	NULL
whereas	NULL
no	NULL
interaction	NULL
between	NULL
E47	NULL
and	NULL
the	NULL
pd	NULL
probe	NULL
was	NULL
detected	NULL
when	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
.	NULL

This	NULL
might	NULL
be	NULL
due	NULL
to	NULL
AP-4	NULL
being	NULL
more	NULL
abundantly	NULL
expressed	NULL
than	NULL
E47	NULL
and/or	NULL
having	NULL
a	NULL
higher	NULL
intrinsic	NULL
affinity	NULL
for	NULL
the	NULL
pd	NULL
element	NULL
.	NULL

AP-4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
sites	NULL
in	NULL
both	NULL
promoter	NULL
and	NULL
enhancer	NULL
regions	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
enhancers	NULL
.	NULL

For	NULL
Transcription	NULL
factor	NULL
AP-4	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
x	NULL
promoter	NULL
E-boxes	NULL
437	NULL
instance	NULL
,	NULL
a	NULL
sequence	NULL
conserved	NULL
in	NULL
several	NULL
enhancers	NULL
of	NULL
pancreatic	NULL
cell-specific	NULL
genes	NULL
is	NULL
also	NULL
conserved	NULL
within	NULL
the	NULL
amylase	NULL
2A	NULL
enhancer	NULL
and	NULL
contains	NULL
an	NULL
AP-4-recognition	NULL
sequence	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
site	NULL
inactivates	NULL
enhancer	NULL
activity	NULL
and	NULL
abolishes	NULL
binding	NULL
of	NULL
AP-4	NULL
in	NULL
vitro	NULL
[	NULL
33	NULL
]	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
human	NULL
proenkephalin	NULL
gene	NULL
[	NULL
34	NULL
]	NULL
,	NULL
the	NULL
metallothionein	NULL
IIA	NULL
gene	NULL
,	NULL
the	NULL
polyoma	NULL
virus	NULL
and	NULL
the	NULL
SV40	NULL
virus	NULL
[	NULL
20,35	NULL
]	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
bovine	NULL
leukaemia	NULL
virus	NULL
long-terminal	NULL
repeat	NULL
[	NULL
36	NULL
]	NULL
,	NULL
the	NULL
distal	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
porcine	NULL
insulin-like	NULL
growth-factor	NULL
binding	NULL
protein-2	NULL
gene	NULL
[	NULL
37	NULL
]	NULL
,	NULL
the	NULL
human	NULL
angiotensinogen	NULL
gene	NULL
promoter	NULL
region	NULL
[	NULL
38	NULL
]	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type-l	NULL
(	NULL
HIV-1	NULL
)	NULL
TATA	NULL
element	NULL
[	NULL
17	NULL
]	NULL
,	NULL
have	NULL
all	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
AP-4	NULL
.	NULL

The	NULL
exact	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
AP-4	NULL
influences	NULL
transcription	NULL
at	NULL
these	NULL
different	NULL
sites	NULL
is	NULL
,	NULL
however	NULL
,	NULL
not	NULL
known	NULL
and	NULL
in	NULL
several	NULL
cases	NULL
AP-4	NULL
has	NULL
even	NULL
been	NULL
proposed	NULL
to	NULL
repress	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
binding	NULL
of	NULL
AP-4	NULL
to	NULL
the	NULL
HIV-1	NULL
TATA	NULL
element	NULL
in	NULL
vitro	NULL
was	NULL
found	NULL
to	NULL
compete	NULL
for	NULL
TATA-box	NULL
binding	NULL
protein	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
,	NULL
and	NULL
to	NULL
inhibit	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
[	NULL
17	NULL
]	NULL
.	NULL

Co-transfection	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
AP-4	NULL
coding	NULL
sequences	NULL
down-regulated	NULL
the	NULL
expression	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
human	NULL
angiotensinogen	NULL
gene	NULL
promoter	NULL
[	NULL
38	NULL
]	NULL
and	NULL
diminished	NULL
Tax-activated	NULL
expression	NULL
from	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
bovine	NULL
leukaemia	NULL
virus	NULL
long-terminal	NULL
repeat	NULL
[	NULL
36	NULL
]	NULL
.	NULL

Within	NULL
the	NULL
late	NULL
promoter	NULL
region	NULL
of	NULL
SV40	NULL
,	NULL
AP-4	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
conferring	NULL
significant	NULL
levels	NULL
of	NULL
nuclease	NULL
sensitivity	NULL
,	NULL
thus	NULL
implicating	NULL
AP-4	NULL
in	NULL
chromatin	NULL
remodelling	NULL
[	NULL
35	NULL
]	NULL
.	NULL

Based	NULL
on	NULL
its	NULL
homology	NULL
to	NULL
transcription	NULL
factors	NULL
Myc	NULL
and	NULL
Max	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
AP-4	NULL
might	NULL
bind	NULL
its	NULL
target	NULL
sequence	NULL
even	NULL
when	NULL
incorporated	NULL
into	NULL
nucleosomes	NULL
,	NULL
thereby	NULL
allowing	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
bind	NULL
in	NULL
a	NULL
co-operative	NULL
manner	NULL
[	NULL
35	NULL
]	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
function	NULL
of	NULL
AP-4	NULL
being	NULL
that	NULL
of	NULL
a	NULL
'nucleating	NULL
'	NULL
protein	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
.	NULL

Here	NULL
,	NULL
its	NULL
function	NULL
would	NULL
be	NULL
to	NULL
facilitate	NULL
other	NULL
protein	NULL
interactions	NULL
,	NULL
rather	NULL
than	NULL
being	NULL
an	NULL
activator	NULL
per	NULL
se	NULL
.	NULL

This	NULL
is	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
earlier	NULL
data	NULL
on	NULL
the	NULL
orientation	NULL
dependency	NULL
of	NULL
the	NULL
pd	NULL
element	NULL
,	NULL
and	NULL
that	NULL
the	NULL
pd	NULL
element	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
an	NULL
Spl	NULL
element	NULL
[	NULL
16	NULL
]	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
AP-4	NULL
also	NULL
bound	NULL
the	NULL
pd-E-box	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
a	NULL
murine	NULL
plasmacytoma	NULL
(	NULL
$	NULL
194	NULL
)	NULL
,	NULL
since	NULL
this	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
used	NULL
to	NULL
show	NULL
that	NULL
the	NULL
transcriptional	NULL
synergy	NULL
between	NULL
the	NULL
pd	NULL
element	NULL
and	NULL
the	NULL
octamer	NULL
is	NULL
specific	NULL
for	NULL
cell	NULL
lines	NULL
representing	NULL
late	NULL
stages	NULL
of	NULL
differentiation	NULL
[	NULL
15	NULL
]	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
AP-4	NULL
is	NULL
the	NULL
major	NULL
E-box	NULL
ligand	NULL
within	NULL
«	NULL
promoters	NULL
.	NULL

This	NULL
finding	NULL
would	NULL
indicate	NULL
that	NULL
there	NULL
is	NULL
a	NULL
division	NULL
of	NULL
labour	NULL
within	NULL
the	NULL
Ig	NULL
loci	NULL
,	NULL
where	NULL
the	NULL
£24	NULL
gene	NULL
products	NULL
primarily	NULL
interact	NULL
with	NULL
and	NULL
regulate	NULL
enhancer	NULL
elements	NULL
,	NULL
whereas	NULL
AP-4	NULL
would	NULL
be	NULL
the	NULL
primary	NULL
promoter	NULL
E-box	NULL
ligand	NULL
.	NULL

The	NULL
further	NULL
consequences	NULL
of	NULL
this	NULL
finding	NULL
with	NULL
regard	NULL
to	NULL
developmental	NULL
regulation	NULL
of	NULL
the	NULL
Ig	NULL
loci	NULL
and	NULL
communication	NULL
between	NULL
enhancer	NULL
and	NULL
promoter	NULL
elements	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

We	NULL
thank	NULL
Dr	NULL
R.B	NULL
.	NULL

Gaynor	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
AP-4	NULL
cDNA	NULL
and	NULL
the	NULL
anti-AP-4	NULL
antibody	NULL
,	NULL
Dr.	NULL
M.	NULL
Sigvardsson	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
various	NULL
reporter	NULL
plasmids	NULL
and	NULL
E47	NULL
expression	NULL
constructs	NULL
,	NULL
Dr.	NULL
M.	NULL
Bemark	NULL
for	NULL
useful	NULL
discussions	NULL
,	NULL
and	NULL
D.	NULL
Liberg	NULL
for	NULL
a	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Swedish	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
,	NULL
the	NULL
Swedish	NULL
Natural	NULL
Sciences	NULL
Research	NULL
Council	NULL
,	NULL
and	NULL
by	NULL
the	NULL
Basque	NULL
Government	NULL
through	NULL
a	NULL
fellowship	NULL
(	NULL
Programa	NULL
de	NULL
Formacion	NULL
de	NULL
Investigadores	NULL
del	NULL
Departamento	NULL
de	NULL
Educacion	NULL
,	NULL
Universidades	NULL
e	NULL
Investigacion	NULL
)	NULL
to	NULL
A	NULL
.	NULL

A.	NULL
REFERENCES	NULL
1	NULL
-	NULL
Strohal	NULL
,	NULL
R.	NULL
,	NULL
Helmberg	NULL
,	NULL
A.	NULL
,	NULL
Kroemer	NULL
,	NULL
G.	NULL
and	NULL
Kofler	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Mouse	NULL
Vk	NULL
gene	NULL
classification	NULL
by	NULL
nucleic	NULL
acid	NULL
sequence	NULL
similarity	NULL
.	NULL

Immunogenstics	NULL
30	NULL
,	NULL
475-493	NULL
2	NULL
-	NULL
Schable	NULL
,	NULL
K.	NULL
F.	NULL
and	NULL
Zachau	NULL
,	NULL
H.-G.	NULL
(	NULL
1993	NULL
)	NULL
The	NULL
variable	NULL
genes	NULL
of	NULL
the	NULL
human	NULL
immunoglobulin	NULL
x	NULL
locus	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

Hoppe-Seyler	NULL
374	NULL
,	NULL
1001-1022	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
Falkner	NULL
,	NULL
F.	NULL
G.	NULL
and	NULL
Zachau	NULL
,	NULL
H.	NULL
G.	NULL
(	NULL
1984	NULL
)	NULL
Correct	NULL
transcription	NULL
of	NULL
an	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
requires	NULL
an	NULL
upstream	NULL
fragment	NULL
containing	NULL
conserved	NULL
sequence	NULL
elements	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
310	NULL
,	NULL
71-74	NULL
Bemark	NULL
,	NULL
M.	NULL
,	NULL
Liberg	NULL
,	NULL
D.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Conserved	NULL
sequence	NULL
elements	NULL
in	NULL
x	NULL
promoters	NULL
from	NULL
mice	NULL
and	NULL
humans	NULL
:	NULL
implications	NULL
for	NULL
transcriptional	NULL
regulation	NULL
and	NULL
repertoire	NULL
expression	NULL
.	NULL

Immunogenetics	NULL
47	NULL
,	NULL
183-195	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
Lymphoid-specific	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
conserved	NULL
octamer	NULL
site	NULL
:	NULL
who	NULL
is	NULL
doing	NULL
what	NULL
?	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
155-163	NULL
Bergman	NULL
,	NULL
Y.	NULL
,	NULL
Rice	NULL
,	NULL
D.	NULL
,	NULL
Grossched	NULL
!	NULL

,	NULL
R.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
Two	NULL
regulatory	NULL
elements	NULL
for	NULL
immunoglobulin	NULL
x	NULL
light	NULL
chain	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
81	NULL
,	NULL
7041-7045	NULL
Wirth	NULL
,	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
An	NULL
octamer	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
a	NULL
TATA	NULL
motif	NULL
is	NULL
sufficient	NULL
for	NULL
Iymphoid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
329	NULL
,	NULL
174-178	NULL
Eaton	NULL
,	NULL
S.	NULL
and	NULL
Calams	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Multiple	NULL
DNA	NULL
sequence	NULL
elements	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
function	NULL
of	NULL
an	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
84	NULL
,	NULL
7634-7638	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
Bemark	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Stimulation	NULL
of	NULL
x	NULL
transcription	NULL
by	NULL
a	NULL
decamer-dependent	NULL
,	NULL
synergistic	NULL
mechanism	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
298-301	NULL
Hagbom	NULL
,	NULL
E.	NULL
,	NULL
Magnusson	NULL
,	NULL
A-C.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Functional	NULL
modularity	NULL
in	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
4347-4354	NULL
Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Differences	NULL
and	NULL
similarities	NULL
in	NULL
DNA-binding	NULL
preferences	NULL
of	NULL
MyoD	NULL
and	NULL
E2A	NULL
protein	NULL
complexes	NULL
revealed	NULL
by	NULL
binding	NULL
site	NULL
selection	NULL
.	NULL

Science	NULL
250	NULL
,	NULL
1104-1110	NULL
Schlissel	NULL
,	NULL
M.	NULL
,	NULL
Voronova	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Helix-loop-helix	NULL
transcription	NULL
factor	NULL
E47	NULL
activates	NULL
germ-ling	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
transcription	NULL
and	NULL
rearrangement	NULL
in	NULL
a	NULL
pre-T-cell	NULL
line	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

§	NULL
,	NULL
1367-1376	NULL
Choi	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Shen	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
Radomska	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Eckhardt	NULL
,	NULL
L.	NULL
A.	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
E47	NULL
activates	NULL
the	NULL
Ig-heavy	NULL
chain	NULL
and	NULL
TdT	NULL
loci	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
5014-5021	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
Overlapping	NULL
expression	NULL
of	NULL
early	NULL
B-cell	NULL
factor	NULL
and	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
as	NULL
a	NULL
mechanism	NULL
to	NULL
dictate	NULL
B-lingage-specific	NULL
activity	NULL
of	NULL
the	NULL
A5	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
3640-3654	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
Bemark	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Pentadecamer-binding	NULL
proteins	NULL
:	NULL
definition	NULL
of	NULL
two	NULL
independent	NULL
protein-binding	NULL
sites	NULL
needed	NULL
for	NULL
functional	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1343-1352	NULL
Bemark	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Diverse	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
quantitative	NULL
regulation	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
x	NULL
promoters	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27	NULL
,	NULL
1308-1318	NULL
Ou	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Garcia-Martinez	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Paulssen	NULL
,	NULL
E.	NULL
J.	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Role	NULL
of	NULL
flanking	NULL
E	NULL
box	NULL
motifs	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
TATA	NULL
element	NULL
function	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
7188-7199	NULL
Liberg	NULL
,	NULL
D.	NULL
,	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
Bemark	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Differentiation-specific	NULL
,	NULL
octamer-dependent	NULL
costimulation	NULL
of	NULL
x	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
3899-3907	NULL
Hu	NULL
,	NULL
Y.	NULL
F.	NULL
,	NULL
Luscher	NULL
,	NULL
B.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Mermod	NULL
,	NULL
N.	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Transcription	NULL
factor	NULL
AP-4	NULL
contains	NULL
multiple	NULL
dimerization	NULL
domains	NULL
that	NULL
regulate	NULL
dimer	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1741-1752	NULL
Mermod	NULL
,	NULL
N.	NULL
,	NULL
Williams	NULL
,	NULL
T.	NULL
J.	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Enhancer	NULL
binding	NULL
factors	NULL
AP-4	NULL
and	NULL
AP-1	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
activate	NULL
SV40	NULL
late	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Nature	NULL
{	NULL
London	NULL
)	NULL
332	NULL
,	NULL
557-561	NULL
Littlewood	NULL
,	NULL
T.	NULL
and	NULL
Evan	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Transcription	NULL
factors	NULL
2	NULL
:	NULL
helix-loop-helix	NULL
.	NULL

In	NULL
Protein	NULL
Profile	NULL
.	NULL

pp	NULL
.	NULL

632-635	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
Chichester	NULL
King-Jones	NULL
,	NULL
K.	NULL
,	NULL
Korge	NULL
,	NULL
G.	NULL
and	NULL
Lehmann	NULL
,	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
The	NULL
helix-loop-helix	NULL
proteins	NULL
dAP-4	NULL
and	NULL
daughterless	NULL
bind	NULL
both	NULL
/r	NULL
vifro	NULL
and	NULL
in	NULL
vivo	NULL
to	NULL
SEBP3	NULL
sites	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
Drosophila	NULL
gene	NULL
Sgs-4	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

291	NULL
,	NULL
71-82	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
edn	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Parslow	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Blair	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Murphy	NULL
,	NULL
W.	NULL
J.	NULL
and	NULL
Granner	NULL
,	NULL
D.	NULL
K.	NULL
(	NULL
1984	NULL
)	NULL
Structure	NULL
of	NULL
the	NULL
5	NULL
``	NULL
ends	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
:	NULL
a	NULL
novel	NULL
conserved	NULL
sequence	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
81	NULL
,	NULL
2650-2654	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Positive	NULL
transcriptional	NULL
control	NULL
elements	NULL
within	NULL
the	NULL
SP6	NULL
x	NULL
promoter	NULL
decamer	NULL
3	NULL
``	NULL
flanking	NULL
sequence	NULL
.	NULL

Mol	NULL
.	NULL

Immunol	NULL
.	NULL

31	NULL
,	NULL
1005-1016	NULL
Liberg	NULL
,	NULL
D.	NULL
,	NULL
Sigvardsson	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Oct	NULL
proteins	NULL
are	NULL
qualitative	NULL
rather	NULL
than	NULL
quantitative	NULL
regulators	NULL
of	NULL
x	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Immunol	NULL
.	NULL

34	NULL
,	NULL
979-986	NULL
Atchison	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Delmas	NULL
,	NULL
V.	NULL
and	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
A	NULL
novel	NULL
upstream	NULL
element	NULL
compensates	NULL
for	NULL
an	NULL
ineffectual	NULL
octamer	NULL
motif	NULL
in	NULL
an	NULL
immunoglobulin	NULL
V	NULL
x	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3109-3117	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
438	NULL
A.	NULL
Aranburu	NULL
and	NULL
others	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Involvement	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
898-907	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.	NULL
S.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56	NULL
,	NULL
777-783	NULL
Bemark	NULL
,	NULL
M.	NULL
,	NULL
Olsson	NULL
,	NULL
H.	NULL
,	NULL
Heinegard	NULL
,	NULL
D.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Purification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
SPG	NULL
x	NULL
promoter	NULL
.	NULL

A	NULL
potential	NULL
role	NULL
for	NULL
CArG-box	NULL
binding	NULL
factor-A	NULL
in	NULL
x	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
,	NULL
18881-18890	NULL
Bemark	NULL
,	NULL
M.	NULL
and	NULL
Leanderson	NULL
,	NULL
T.	NULL
(	NULL
1999	NULL
)	NULL
Promotion	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Immunologist	NULL
7	NULL
,	NULL
177-183	NULL
Fodor	NULL
,	NULL
E.	NULL
,	NULL
Weinrich	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Meister	NULL
,	NULL
A.	NULL
,	NULL
Mermod	NULL
,	NULL
N.	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
A	NULL
pancreatic	NULL
exocrine	NULL
cell	NULL
factor	NULL
and	NULL
AP4	NULL
bind	NULL
overlapping	NULL
sites	NULL
in	NULL
the	NULL
amylase	NULL
2A	NULL
enhancer	NULL
.	NULL

Biochemistry	NULL
30	NULL
,	NULL
8102-8108	NULL
Received	NULL
23	NULL
August	NULL
2000/23	NULL
November	NULL
2000	NULL
;	NULL
accepted	NULL
2	NULL
January	NULL
2001	NULL
©	NULL
2001	NULL
Biochemical	NULL
Society	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
Comb	NULL
,	NULL
M.	NULL
,	NULL
Mermod	NULL
,	NULL
N.	NULL
,	NULL
Hyman	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Pearlberg	NULL
,	NULL
J.	NULL
,	NULL
Ross	NULL
,	NULL
M.	NULL
E.	NULL
and	NULL
Goodman	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Proteins	NULL
bound	NULL
at	NULL
adjacent	NULL
DNA	NULL
elements	NULL
act	NULL
synergistically	NULL
to	NULL
regulate	NULL
human	NULL
proenkephalin	NULL
cAMP	NULL
inducible	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
3793-3805	NULL
Frigz	NULL
,	NULL
M.	NULL
,	NULL
Hermansen	NULL
,	NULL
R.	NULL
and	NULL
Milavetz	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Chromatin	NULL
structure	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
late	NULL
promoter	NULL
:	NULL
a	NULL
deletional	NULL
analysis	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

73	NULL
,	NULL
1990-1997	NULL
Unk	NULL
,	NULL
I.	NULL
,	NULL
Kigs-Toth	NULL
,	NULL
E.	NULL
and	NULL
Boros	NULL
,	NULL
1	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Transcription	NULL
factor	NULL
AP-4	NULL
participates	NULL
in	NULL
activation	NULL
of	NULL
bovine	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
by	NULL
p34	NULL
Tax	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
4872-4875	NULL
Badinga	NULL
,	NULL
L.	NULL
,	NULL
Song	NULL
,	NULL
S.	NULL
,	NULL
Simmen	NULL
,	NULL
R.	NULL
C.	NULL
and	NULL
Simmen	NULL
,	NULL
F.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
A	NULL
distal	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
insulin-like	NULL
growth	NULL
factor	NULL
binding	NULL
protein-2	NULL
(	NULL
IGFBP-2	NULL
)	NULL
gene	NULL
interacts	NULL
with	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
transcription	NULL
factor	NULL
,	NULL
AP-4	NULL
.	NULL

Endocrine	NULL
8	NULL
,	NULL
281-289	NULL
Cui	NULL
,	NULL
Y.	NULL
,	NULL
Narayanan	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Zhou	NULL
,	NULL
J.	NULL
and	NULL
Kumar	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Exon-1	NULL
is	NULL
involved	NULL
in	NULL
positive	NULL
as	NULL
well	NULL
as	NULL
negative	NULL
regulation	NULL
of	NULL
human	NULL
angiotensinogen	NULL
gene	NULL
expression	NULL
.	NULL

Gene	NULL
224	NULL
,	NULL
97-107	NULL

